CDKN2A and cancer: Furthermore, “...Dysregulation of these core pathways and processes through mutation can explain the major features of pancreatic tumorigenesis.” Jones et al. [30] indicate that genetic alterations in the CDKN2A, SMAD4, and TP53 tumor suppressor genes and in the KRAS oncogene have been identified in this lethal cancer.